Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
2.72
0.02 (0.74%)
At close: Oct 03, 2025, 3:59 PM
2.72
0.00%
Pre-market: Oct 06, 2025, 06:42 AM EDT
Chemomab Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 33.69K | 26.9K | 26.9K | 43.07K | 62.01K | 50.93K | 9.1M | 9.1M | 17.4M | 23.63M | 14.6M | 14.6M | 6.29M | 40.15K | 34.04K | 26.02K | 20K | 16K |
Gross Profit | -33.69K | -26.9K | -26.9K | -43.07K | -62.01K | -50.93K | -9.1M | -9.1M | -17.4M | -23.63M | -14.6M | -14.6M | -6.29M | -40.15K | -34.04K | -22.99K | -13.95K | -6.93K |
Operating Income | -12.67M | -14.18M | -14.74M | -15.37M | -16.03M | -20.46M | -25.48M | -30.27M | -34.22M | -32.28M | -28.53M | -24.91M | -19.49M | -15.99M | -12.37M | -9.29M | -7.62M | -5.97M |
Interest Income | 851.69K | 778.92K | 797.77K | 981.45K | 984.42K | 1.1M | 1.24M | 1.18M | 1.18M | 928.12K | 830.55K | 451.57K | 216.47K | 216.47K | n/a | 84.68K | 91.73K | 93.75K |
Pretax Income | -11.83M | -13.4M | -13.95M | -14.44M | -15.09M | -19.3M | -24.09M | -28.87M | -32.75M | -31.56M | -28.01M | -24.81M | -19.78M | -15.9M | -12.5M | -9.42M | -7.66M | -5.96M |
Net Income | -11.83M | -13.4M | -13.95M | -14.44M | -15.02M | -19.36M | -24.25M | -29.06M | -33.31M | -31.53M | -27.88M | -24.65M | -19.3M | -15.88M | -12.48M | -9.39M | -7.65M | -5.96M |
Selling & General & Admin | 3.65M | 3.51M | 3.41M | 3.36M | 3.47M | 5.81M | 7.07M | 9.07M | 10.98M | 11.14M | 11.56M | 11.45M | 9.96M | 8.07M | 6.03M | 4.08M | 2.87M | 1.68M |
Research & Development | 9.03M | 10.67M | 11.32M | 12.03M | 12.54M | 14.63M | 18.37M | 21.15M | 23.23M | 21.12M | 16.98M | 13.46M | 9.53M | 7.92M | 6.33M | 5.21M | 4.75M | 4.29M |
Other Expenses | n/a | n/a | 5K | -12K | -12K | -12K | -17K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 12.67M | 14.18M | 14.74M | 15.37M | 16M | 20.43M | 25.43M | 30.22M | 34.2M | 32.26M | 28.53M | 24.91M | 19.49M | 15.99M | 12.37M | 9.29M | 7.62M | 5.97M |
Interest Expense | n/a | n/a | 2K | 2K | 2K | 2K | n/a | 27K | 264K | 738.35K | 738.35K | 723.4K | 563.76K | 106.48K | 111.43K | 99.37K | 22.01K | 4.95K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.67M | 14.18M | 14.78M | 15.46M | 16.1M | 20.53M | 25.49M | 30.24M | 34.2M | 32.26M | 28.53M | 24.91M | 19.49M | 15.99M | 12.37M | 9.29M | 7.62M | 5.97M |
Income Tax Expense | n/a | n/a | n/a | n/a | -54.82K | -20.82K | 178.00 | 10.18K | 302K | -276K | -297.03K | -307.08K | -544.12K | -145.93 | -45.45 | 4.55 | 46.68 | 72.48 |
Shares Outstanding (Basic) | 1.16M | 22.81M | 18.86M | 17.53M | 14.3M | 14.21M | 13.01M | 11.82M | 11.08M | 11.05M | 11.63M | 11.44M | 11.41M | 11.4M | 11.4M | 11.4M | 10.81M | 7.84M |
Shares Outstanding (Diluted) | 1.16M | 22.81M | 18.86M | 17.53M | 14.3M | 14.21M | 13.01M | 11.82M | 11.08M | 11.05M | 11.63M | 11.44M | 11.41M | 11.4M | 11.4M | 11.4M | 10.81M | 7.84M |
EPS (Basic) | -2.4 | -0.75 | -0.89 | -0.99 | -1.14 | -1.6 | -2.2 | -2.6 | -2.8 | -2.8 | -2.4 | -2.2 | -1.68 | -1.4 | -1.18 | -1.9 | -3 | -4.6 |
EPS (Diluted) | -2.4 | -0.75 | -0.89 | -0.99 | -1.14 | -1.6 | -2.2 | -2.6 | -2.8 | -2.8 | -2.4 | -2.2 | -1.68 | -1.4 | -1.18 | -1.9 | -3 | -4.6 |
EBITDA | -12.48M | -14.18M | -14.74M | -15.37M | -16.03M | -20.44M | -25.43M | -30.21M | -34.14M | -32.2M | -28.48M | -24.86M | -19.44M | -15.95M | -12.33M | -9.26M | -7.59M | -5.94M |
EBIT | -12.51M | -14.18M | -14.74M | -15.37M | -16.03M | -20.46M | -25.46M | -30.25M | -34.2M | -32.26M | -28.53M | -24.91M | -19.49M | -15.99M | -12.37M | -9.29M | -7.62M | -5.97M |
Depreciation & Amortization | 69.94K | 49.75K | 53.25K | 63.17K | 65.36K | 67.68K | 66.78K | 64.57K | 62.49K | 60.51K | 57.69K | 54.78K | 46.95K | 40.15K | 34.12K | 29.07K | 28.02K | 26K |